Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to -$146000.0.

  • Cytosorbents' Exchange Rate Effect fell 27176.47% to -$146000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $33324.0, marking a year-over-year increase of 14296.32%. This contributed to the annual value of -$84676.0 for FY2024, which is 1512.79% up from last year.
  • Latest data reveals that Cytosorbents reported Exchange Rate Effect of -$146000.0 as of Q3 2025, which was down 27176.47% from $259088.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Exchange Rate Effect ranged from a high of $259088.0 in Q2 2025 and a low of -$160491.0 during Q3 2022
  • For the 5-year period, Cytosorbents' Exchange Rate Effect averaged around -$17533.8, with its median value being -$4938.0 (2021).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first tumbled by 315012.15% in 2022, then skyrocketed by 47128.2% in 2025.
  • Quarter analysis of 5 years shows Cytosorbents' Exchange Rate Effect stood at $27592.0 in 2021, then skyrocketed by 402.81% to $138734.0 in 2022, then tumbled by 171.05% to -$98564.0 in 2023, then dropped by 7.22% to -$105676.0 in 2024, then crashed by 38.16% to -$146000.0 in 2025.
  • Its last three reported values are -$146000.0 in Q3 2025, $259088.0 for Q2 2025, and $25912.0 during Q1 2025.